Peter Heerma, Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 1,779 shares at $21.75 ($39K) on 2023-02-01, disclosed to the SEC on 2023-02-02.
Open-market sale of $39k TVTX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |